News and Trends 28 Jul 2020 Record Series A for Italian Biotech Funds Autoimmune Therapy Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for type 1 diabetes and inflammatory bowel disease and take it to human trials. Enthera was founded in 2016 and is the first company to ‘graduate’ from the BiovelocITA accelerator program in Milan, which is supported by French life science investor […] July 28, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jul 2020 Biological Fungicide Clears Wheat of Rust Disease in European Field Trial A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and other major fungal diseases at bay. Developed by French company Amoéba, this product could provide an eco-friendly solution to a growing problem in agriculture worldwide. Every year, over 5 million tons of wheat are lost to rust disease globally, which […] July 27, 2020 - 2 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jul 2020 Swiss Company Raises €23M to Smash Cancer with Bacteria Basel-based T3 Pharmaceuticals has closed its third financing round, worth over €23.3M (CHF 25M), to develop a bacterial cancer therapy. Since T3 Pharma was spun off from the University of Basel in 2015, the firm has raised €37M (CHF 40M). The fundraiser included investors such as Boehringer Ingelheim Venture Fund, Reference Capital, and Wille Finance. […] July 24, 2020 - 2 minutesmins - By Antara Mazumdar Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jul 2020 Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company CureVac to co-develop messenger RNA drugs for infectious diseases. Under the terms of the deal, GSK will fund the development and manufacturing of up to five mRNA-based vaccines and antibody drugs targeting undisclosed infectious diseases. CureVac’s current rabies and Covid-19 […] July 23, 2020 - 3 minutesmins - By David Wilson Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jul 2020 Inhaled Treatment Reduces Severe Covid-19 Risk by 79% An experimental Covid-19 treatment that is delivered directly to the lungs via a nebulizer reduced the risk of mortality and the need for mechanical ventilation in a phase II trial. In the trial, the lead candidate of UK-based biotech Synairgen drove down by 79% the risk of severe disease symptoms such as requiring mechanical ventilation […] July 22, 2020 - 3 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jul 2020 Global €870M Fund Launched to Address Antimicrobial Resistance A global collaboration including the pharmaceutical industry and public funders such as the European Investment Bank has committed to investing €870M ($1B) in tackling the growing crisis of antibiotic-resistant superbugs. So far, over 20 pharmaceutical companies globally have contributed to the fund, called the AMR Action Fund. They are joined by other organizations such as […] July 21, 2020 - 3 minutesmins - By Manuela Callari Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2020 Russian Hackers Launch Cyber Attack on Covid-19 Vaccine Developers The National Cyber Security Centre (NCSC) in the UK stated this week that several organizations involved in Covid-19 vaccine development in the UK, US, and Canada have been targeted in a cyber attack by a Russian hacking group known as APT29. The NCSC says that APT29, also known as ‘the Dukes’ or ‘Cozy Bear,’ is […] July 17, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2020 Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment Unfazed by the financial turmoil caused by the Covid-19 pandemic, the Edinburgh-based firm Macomics and University of Cambridge spinout Spirea have each closed seed rounds this week to finance the development of novel cancer immunotherapies and more precise forms of chemotherapy. Macomics bagged €3.5M (£3.2M) in seed funding from the transatlantic VC firm Epidarex Capital […] July 17, 2020 - 3 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2020 Danish Wound Healing Biotech Raises €20M to Accelerate US Rollout Reapplix, a Danish biotech focusing on developing wound healing technology, has raised €19.8M in equity funding to commercialize a treatment for diabetic foot ulcers in the US. The company also announced it has received Medicare reimbursement instructions that it will receive an average of €1,420 ($1,623) for each patient in the US that receives its […] July 17, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jul 2020 European Biotech Stocks Shine Amid 2020 Market Slump As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile biotech stocks are outperforming most other sectors of the economy. Experts say this trend is likely to continue. Financial markets are in flux and according to a recent study by the Boston Consulting Group, the global economic slump caused by […] July 16, 2020 - 4 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jul 2020 Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments UK-based biopharmaceutical Amryt Pharma has listed on the Nasdaq Stock Market in a move to increase its US presence as it commercializes treatments for rare diseases such as the skin condition epidermolysis bullosa. The company did not raise any extra capital by releasing new shares in this debut, as is typical for most listings. But it […] July 14, 2020 - 3 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jul 2020 €32M Series B to Fund Bleeding Medication Inspired by Snake Venom The Dutch biotech VarmX will use the proceedings of a €32M Series B to take a blood clotting protein drug into clinical trials by 2021, as well as strengthening its manufacturing and R&D capabilities. More than 10 million patients in the US and Europe at risk of blood clots and strokes receive blood thinners that […] July 14, 2020 - 2 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email